Pharmaron Manufacturing Services US LLC

Pharmaceutical company · Coventry, Rhode Island, United States

Pharmaron Manufacturing Services US LLC is a pharmaceutical company with a registered site in Coventry, Rhode Island, United States. The US FDA lists 1 drug manufacturing or testing site registered to the company.

Profile compiled from public records. Is this your company? Request a correction or update

Pharmaron Manufacturing Services US at a glance

Typepharmaceutical company

Registered siteCoventry, Rhode Island, United States

FDA-registered sites1

What does Pharmaron Manufacturing Services US do?

Operations at its FDA-registered drug sites

AnalysisAPI manufacturingLabelingManufacturingPackingParticle size reductionRepacking

Where is Pharmaron Manufacturing Services US located?

Registered site: Coventry, Rhode Island, United States

Coventry, Rhode IslandPharmaron Manufacturing Services (US) LLC · FDA drug site

Frequently asked questions about Pharmaron Manufacturing Services US

Where is Pharmaron Manufacturing Services US based?

Pharmaron Manufacturing Services US LLC is based in Coventry, Rhode Island, United States.

What does Pharmaron Manufacturing Services US do?

Pharmaron Manufacturing Services US LLC is a pharmaceutical company. Its FDA-registered drug sites are registered for analysis, API manufacturing, labeling and manufacturing.

Similar companies

AbbVie Inc.North Chicago, Illinois, United States
Savara IncAustin, Texas, United States
Crinetics Pharmaceuticals, Inc.San Diego, California, United States
Cartesian Therapeutics, Inc.Frederick, Maryland, United States
Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
Dare Bioscience, Inc.San Diego, California, United States
Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
Marker Therapeutics, Inc.Houston, Texas, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences